Delaware Code § 18-3338A

Equal reimbursement for oral and intravenous anticancer medication
Open in Lexace · Ask the AI about this section
(a) Every individual policy or contract of health insurance, or certificate issued thereunder, which is delivered, issued for delivery,
renewed, modified, altered, or amended in this State on or after January 1, 2013, and which provides medical, major medical, or similar

comprehensive-type coverage, and provides coverage for prescription drugs, and which also provides coverage for anticancer medication,
must provide coverage for a prescribed, orally administered anticancer medication used to kill or slow the growth of cancerous cells, and
must apply the lower cost sharing of either:
(1) Anticancer medication under the prescription drug benefit; or
(2) Intravenous or injected anticancer medications.
For purposes of this section, the term "cost sharing" may include co-pays, coinsurance, and deductibles, as considered appropriate by
the Commissioner.
(b) An insurer who provides coverage under this section and any participating entity through which the insurer offers health services
may not:
(1) Vary the terms of the policy for the purpose of or with the effect of avoiding compliance with this section;
(2) Provide incentives, monetary or otherwise, to encourage a covered person to accept less than the minimum protections available
under this section;
(3) Penalize in any way or reduce or limit the compensation of a healthcare practitioner for recommending or providing care to a
covered person in accordance with this section;
(4) Provide incentives, monetary or otherwise, to a healthcare practitioner relating to the services provided pursuant to this section,
intended to induce or have the effect of inducing the practitioner to provide care to a covered person in a manner inconsistent with
this section; or
(5) Achieve compliance with this section by imposing an increase in cost sharing for an oral, intravenous, or injected anticancer
medication covered under the policy on and following May 1, 2012.
(c) Nothing in this section may be interpreted to prohibit an insurer from requiring prior authorization for any anticancer treatment.
(d) Nothing in this section may be interpreted to require coverage for anticancer medication.

‹ Prev All Delaware sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.